Login / Signup

Use of Sotrovimab in 14 Children with COVID-19: A Single-center Experience.

Sarina Kim ButzerSandra HabbigKatrin MehlerSophie HaumannMeike MeyerNorma JungAndré Oberthür
Published in: The Pediatric infectious disease journal (2022)
Children affected by coronavirus disease 2019 (COVID-19) with preexisting comorbidities are at risk of complications. Monoclonal antibodies prevent severe COVID-19 courses in adults but data on children are scarce. Here we report on the use of Sotrovimab in 14 children at risk of severe disease treated at the University of Cologne Children's Hospital. Tolerability was good and no infusion-related reactions were seen.
Keyphrases
  • coronavirus disease
  • young adults
  • sars cov
  • healthcare
  • low dose
  • randomized controlled trial
  • machine learning
  • electronic health record
  • risk factors
  • open label
  • acute care